Artificial cells (Record no. 4080)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01773nam a2200265Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | IN-GtHPI |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20201107112547.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 191113b ii ||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| ISBN | 9812707786 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| DDC Edition No. | 21 |
| Class No. | 615.39 |
| Item number | CHA/A |
| 100 ## - FIRST AUTHOR (IF A PERSON) | |
| Name of author | Chang, Thomas Ming Swi. |
| Role | Author |
| 245 #0 - TITLE STATEMENT | |
| Title | Artificial cells |
| Sub-title | biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy |
| Statement of responsibility | by Thomas Ming Swi Chang. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Hackensack, N. J |
| Name of publisher, distributor, etc. | World Scientific Publishing Co. Pte. Ltd. |
| Date of publication, distribution, etc. | c2007 |
| 300 ## - PHYSICAL DESCRIPTION | |
| No. of pages | xxvi, 455p. |
| Other physical details | ill. (some col.) |
| Dimensions | 24cm. |
| 490 ## - SERIES STATEMENT | |
| Series statement | Regenerative medicine, artificial cells and nanomedicine |
| Volume/sequential designation | v.1 |
| 500 ## - GENERAL NOTE | |
| General note | Includes bibliographical references (p. 377-440) and index. |
| 505 ## - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 50th anniversary of artificial cells -- Basic principles -- Oxygen carriers based on nanobiotechnology -- A nanobiotechnologic therapeutic that transports oxygen and remove oxygen radicals: for stroke, hemorrhagic shock and related conditions -- Nanotechnology-based artificial red blood cells (RBC's) -- Use of enzyme artificial cells for genetic enzyme defects that increase systemic substrates to toxic levels -- Enzyme artificial cells in substrate-dependent tumors and activation of prodrug -- Artificial cells for cell encapsulation -- Artificial cells containing hepatocytes and/or stem cells in regenerative medicine -- Hemoperfusion in poisoning, kidney failure, liver failure, and immunology -- Perspectives on the future of artificial cells as suggested by past research. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Subject heading | Pharmaceutical Microbiology |
| 9 (RLIN) | 18 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Subject heading | Biology |
| 9 (RLIN) | 22 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Subject heading | Artificial cells |
| 9 (RLIN) | 332 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Subject heading | Blood substitutes |
| 9 (RLIN) | 333 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Subject heading | Biotechnology |
| 9 (RLIN) | 187 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Subject heading | Pharmaceutics |
| 9 (RLIN) | 15 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Reference |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan (e.g. reference copy) | Home library | Current library | Date acquired | Source of acquisition | Purchase price (after disc. etc) | Total Checkouts | Full call number | Accession No | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | Himalayan Pharmacy Institute Library | Himalayan Pharmacy Institute Library | 29/08/2007 | Aryan Publication Pvt.Ltd. Kolkota | 2903.00 | 615.39 CHA/A | 02213 | 05/12/2019 | 05/12/2019 | Reference |